Skip to main content

Table 3 Annual moderate or severe exacerbation rate ratios

From: Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study

 

Treatment initiation group (n)

Follow-up period (person-years)

Number of exacerbations

Rate (95% CI)a

Rate ratio (95% CI)a

Unadjusted

Adjusted

Full analysis set

Delayed (1516)

9491.1

2418

0.30 (0.28, 0.33)

Reference

Reference

Prompt (1466)

6822

1287

0.22 (0.20, 0.25)

0.74 (0.65, 0.84)

0.71 (0.62, 0.80)

By phenotype

 Chronic bronchitis

Delayed (572)

3631.7

1065

0.33 (0.30, 0.37)

Reference

Reference

Prompt (185)

900.9

192

0.26 (0.21, 0.33)

0.78 (0.60, 1.02)

0.75 (0.58, 0.79)

 Emphysema

Delayed (652)

4273.7

986

0.29 (0.25, 0.33)

Reference

Reference

Prompt (671)

3505.9

577

0.20 (0.17, 0.23)

0.69 (0.57, 0.84)

0.69 (0.57, 0.83)

 Unclassified

Delayed (384)

2206.8

507

0.27 (0.23, 0.33)

Reference

Reference

Prompt (774)

3199.6

710

0.25 (0.22, 0.29)

0.92 (0.73, 1.15)

– (–, –)

  1. COPD chronic obstructive pulmonary disease, CI confidence interval
  2. aCalculated by negative binomial model
  3. Covariates in pre-index period include age, sex, number of comorbidities, use of systemic corticosteroids, use of antibiotics, and number of hospitalizations excluding hospitalization due to COPD exacerbation or acute respiratory failure